Vireo Growth (VREOF) Change in Receivables (2020 - 2026)
Vireo Growth's (VREOF) quarterly Change in Receivables came in at $1.1 million in Q1 2026, up 283.33% year-on-year from $286956.5 in Q1 2025, and down 41.22% quarter-over-quarter from $1.9 million in Q4 2025.
Vireo Growth (VREOF) Change in Receivables (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Change in Receivables across 7 years of filings, most recently posting $1.1 million for Q1 2026.
- Change in Receivables for Q1 2026 came in at $1.1 million, up 283.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.8 million (up 896.59% YoY), and the FY2025 annual result was $6.1 million, up 488.6% from the prior year.
- Change in Receivables came in at $1.1 million for Q1 2026 at Vireo Growth, down from $1.9 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $2.9 million in Q2 2025 to a low of -$2.4 million in Q4 2023.
- The 5-year median for Change in Receivables is $221437.0 (2022), against an average of $383347.8.
- Across the five-year window, Change in Receivables surged 3260.33% in 2022 and sank 1326.77% in 2024, its largest moves.
- Vireo Growth's Change in Receivables stood at -$1.6 million in 2022, then slumped by 43.75% to -$2.4 million in 2023, then jumped by 151.16% to $1.2 million in 2024, then jumped by 55.53% to $1.9 million in 2025, then tumbled by 41.22% to $1.1 million in 2026.
- The last three Change in Receivables figures came in at $1.1 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Dec 31, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Sep 30, 2025 | 1.88 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Mar 31, 2025 | -600,000.00 |
| Mar 31, 2025 | -600,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 669,306.00 |
| Sep 30, 2024 | 669,306.00 |
| Jun 30, 2024 | -493,536.00 |
| Jun 30, 2024 | -493,536.00 |
| Mar 31, 2024 | -348,817.00 |
| Mar 31, 2024 | -348,817.00 |
| Dec 31, 2023 | -2.35 Mn |
| Dec 31, 2023 | -2.35 Mn |